CD30 expression can be associated with a malignant phenotype, or reflect the recruitment of an inflammatory milieu that enhances tumor growth and survival.[18] One could argue that CD30 positivity in CM might be the result of MCs activation or allergy and not be related to CM oncogenesis. This evidence concerns the gene TNFRSF8 and allergic disease.